SES
22.9.2022 10:45:52 CEST | Business Wire | Press release
An SES-led consortium of 20 European companies, with the European Space Agency (ESA) and European Commission support, will design, develop, launch and operate the EAGLE-1 satellite-based end-to-end system for secure Quantum Key Distribution (QKD), enabling in-orbit validation and demonstration of next-generation cyber-security across Europe.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20220922005427/en/
SES, ESA and European Commission Partnering to Deliver Satellite Quantum Cryptography System for European Cybersecurity (Graphic: Business Wire)
The groundbreaking partnership between ESA and an SES-led consortium, with the European Commission support, is advancing Europe to the front of space innovation with satellite-enabled QKD. Together with its European partners, SES will build the first sovereign European end-to-end space-based QKD system, developing and operating a dedicated low earth orbit (LEO) satellite and building a state-of-the-art QKD operations centre in Luxembourg. The project is co-funded by the ESA contribution of Germany, Luxembourg, Austria, Italy, the Netherlands, Switzerland, Belgium and the Czech Republic under ARTES, as well as the European Commission through Horizon Europe.
Using the EAGLE-1 system, ESA and the European Union Member States will achieve the first step to demonstrate and validate QKD technologies from low earth orbit to the ground. The EAGLE-1 project will provide valuable mission data for next generation Quantum Communication Infrastructures (QCIs), contributing for example to the EU plans to deploy a sovereign, autonomous cross-border quantum secure communications networks.
The EAGLE-1 satellite is due to launch in 2024 and will then complete three years of in-orbit mission supported by the European Commission. During this operational phase, the satellite will allow European Union governments and institutions as well as critical business sectors early access to long-distance QKD to path the way towards an EU constellation enabling ultra-secure data transmissions.
To implement the ultra-secure cryptographic key exchange system of EAGLE-1, the consortium will develop the QKD payload, terrestrial optical station, scalable quantum operational networks and key management system to interface with national QCIs.
Josef Aschbacher, ESA Director General, said, “European space innovation has gained strong momentum both from a technology perspective and in terms of commercialisation. It allows us to develop and implement next-generation, future-proof projects in space across critical domains like secure communication, next-generation networks and cybersecurity. Led by ESA, partially financed by the European Commission and implemented by SES, EAGLE-1 is a major step towards making the secure and scalable European Quantum Communications Infrastructure a reality.”
Elodie Viau, Director of Telecommunications and Integrated Applications at ESA, said, “In today’s increasingly interconnected world, keeping information secure is paramount. Robust encryption keys as well as technologies enabling their secure distribution are vital to this endeavour. We are proud to forge this partnership between ESA and a consortium led by SES to create the EAGLE-1 highly secure and autonomous quantum key distribution system. ESA enables the European space industry to succeed by federating industry around large-scale programmes, achieving competitive leaps forward.”
“European security and sovereignty in a future world of quantum computing is critical to the success of Europe and its Member States,” said Steve Collar, CEO of SES. “We are proud to leverage our multi-orbit credentials and our innovative platforms and solutions in partnership with ESA, the European Commission and the Luxembourg Government to advance quantum communications and implement the EAGLE-1 system, which is called to be a cornerstone for the development of secure and sovereign European networks of the future.”
For more information, visit the EAGLE-1 Newsroom
Follow us on:
Twitter | Facebook | YouTube | LinkedIn | Instagram
About ESA
The European Space Agency (ESA) is Europe’s gateway to space. ESA is an intergovernmental organisation, created in 1975, with the mission to shape the development of Europe’s space capability and ensure that investment in space delivers benefits to the citizens of Europe and the world. For more information see www.esa.int
The Telecommunications and Integrated Applications Directorate (TIA) supports innovation to boost the competitiveness of European industry in the global space market. This involves a wide range of activities, from space-based technology, systems, products for telecommunications development to the down-to-Earth application of space-based services. It also calls for engagement with a wide range of industrial, academic, and institutional partners. For more information, please visit our website: https://artes.esa.int/
About SES
SES has a bold vision to deliver amazing experiences everywhere on earth by distributing the highest quality video content and providing seamless connectivity around the world. As the leader in global content connectivity solutions, SES operates the world’s only multi-orbit constellation of satellites with the unique combination of global coverage and high performance, including the commercially-proven, low-latency Medium Earth Orbit O3b system. By leveraging a vast and intelligent, cloud-enabled network, SES is able to deliver high-quality connectivity solutions anywhere on land, at sea or in the air, and is a trusted partner to the world’s leading telecommunications companies, mobile network operators, governments, connectivity and cloud service providers, broadcasters, video platform operators and content owners. SES’s video network carries ~8,000 channels and has an unparalleled reach of 366 million households, delivering managed media services for both linear and non-linear content. The company is listed on Paris and Luxembourg stock exchanges (Ticker: SESG). Further information is available at: www.ses.com.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20220922005427/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
AI Meets Traditional Culture: Huangshan Captures Widespread Attention at ITB Berlin7.3.2026 10:22:00 CET | Press release
Huangshan, one of China’s most iconic scenic destinations, drew significant attention at this year’s ITB by presenting a compelling fusion of traditional Chinese culture and cutting-edge artificial intelligence under the slogan “The world of Huangshan is for the world.” This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260307909978/en/ International visitor admires Huangshan cultural and creative exhibits at the Huangshan stand during ITB Berlin. Located in eastern China’s Anhui Province, Huangshan is famed for its “Five Natural Wonders” — fantastic pines, grotesque rocks, sea of clouds, hot spring and winter snow. The mountain is widely regarded as one of China’s greatest mountain landscapes. It is also a rare natural heritage site that simultaneously holds multiple international designations, including UNESCO World Cultural and Natural Heritage status, a UNESCO Global Geopark and a World Biosphere Reserve. At ITB, the Huangsh
Incyte Announces the European Commission Approval of Zynyz® (retifanlimab) for the First-Line Treatment of Advanced Squamous Cell Carcinoma of the Anal Canal (SCAC)6.3.2026 22:42:00 CET | Press release
- Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) is the first systemic treatment for adult patients with advanced SCAC in Europe- The EC approval is based on results of the POD1UM-303 study which showed that adult patients with advanced SCAC achieved significantly improved progression-free survival with Zynyz in combination with carboplatin and paclitaxel as a first-line treatment compared to chemotherapy alone.1 Incyte (Nasdaq:INCY) today announced that the European Commission (EC) has approved Zynyz® (retifanlimab) in combination with carboplatin and paclitaxel (platinum-based chemotherapy) for the first-line treatment of adult patients with metastatic or with inoperable locally recurrent squamous cell carcinoma of the anal canal (SCAC). “The EC approval of Zynyz marks an important step forward for patients with advanced SCAC, a rare cancer for which meaningful treatment advances have not occurred in several decades,” said Bill Meur
Dfns Launches Payouts6.3.2026 21:27:00 CET | Press release
Dfns today announced the launch of Payouts, a new API enabling institutions to convert stablecoins to fiat and route payouts across multiple bank accounts while keeping wallet-level governance and controls in place. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260305327930/en/ Convert stablecoins to fiat and settle payouts to bank accounts in 94 countries, today. Solving the problem of single-rail off-ramps Today, most fintechs and institutions still hard-wire a single payout provider into their stack, or rely on vertically integrated models that bundle routing, pricing, custody, and settlement together. That approach may be convenient early on, but it creates structural problems at scale: weak price discovery because there is no competitive pressure on margins, limited auditability because routing decisions are opaque, and operational fragility because a single provider degradation in any corridor requires architectural i
Klarna Group Plc Clarifies Mechanics of March 9 Lock-Up Expiration6.3.2026 20:23:00 CET | Press release
Klarna Group plc (NYSE: KLAR) today issues the following clarification to ensure investors and market participants have accurate information regarding the mechanics of its lock-up expiration on March 9, 2026, the processes required before pre-IPO shares can be traded on the NYSE, and the prior liquidity opportunities already available to shareholders. This release contains only factual descriptions of the Company's share structure and applicable processes. It does not constitute guidance or a projection of any kind regarding future trading volumes, share price, or the intentions of any shareholder and speaks only as of the date of this press release. 1. 335 million locked-up shares — but two different categories Of the 378 million total ordinary shares outstanding, approximately 335 million are subject to lock-up restrictions expiring March 9, 2026. However, these shares fall into two distinct categories governed by separate sets of regulations. A. 159 million shares (48% of locked-up
Lone Star Funds Announces Agreement to Acquire the Capsules & Health Ingredients Division of Lonza Group AG6.3.2026 18:30:00 CET | Press release
Lone Star Funds (“Lone Star”) today announced that an affiliate of Lone Star Fund XII, L.P. has entered into a definitive agreement to acquire the Capsules & Health Ingredients (“CHI”) division of Lonza Group AG. As part of the transaction, Lonza will retain a 40% equity position in the business. Headquartered in Basel, Switzerland, CHI operates globally across the Americas, Europe and Asia Pacific. The business comprises three segments: Hard Empty Capsules: leading global manufacturer of gelatin and plant-based capsules offering a broad range of innovative solutions for pharmaceutical and nutraceutical customers. Dosage Form Solutions: end-to-end development and manufacturing platform serving nutraceutical and pharmaceutical customers. Health Ingredients: provider of branded, science-backed nutrition ingredients serving joint health, energy and active lifestyle markets. Lone Star believes CHI is a high-quality, globally recognized platform with strong technical capabilities, different
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
